NantHealth to Report 2016 Fourth-Quarter, Full-Year Financial Results and Host Conference Call on Thursday, March 30
March 28, 2017
CULVER CITY, Calif.--(BUSINESS WIRE)--
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based,
personalized healthcare company, today announced that it will report
financial results for its 2016 fourth quarter and full year on Thursday,
March 30, 2017, after market close. NantHealth management will host a
conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review
the company’s performance.
The conference call will be available to interested parties by dialing
844-309-3709 from the U.S. or Canada, or 281-962-4864 from international
locations, passcode 92890709. The call will be broadcast via the
Internet at www.nanthealth.com.
About NantHealth, Inc.
NantHealth, Inc., a member of the NantWorks ecosystem of companies, is a
next-generation, evidence-based, personalized healthcare company
enabling improved patient outcomes and more effective treatment
decisions for critical illnesses. NantHealth's unique systems-based
approach to personalized healthcare applies novel diagnostics tailored
to the specific molecular profiles of patient tissues and integrates
this molecular data in a clinical setting with large-scale, real-time
biometric signal and phenotypic data to track patient outcomes and
deliver precision medicine. For nearly a decade, NantHealth has
developed an adaptive learning system, which includes its unique
software, middleware and hardware systems infrastructure that collects,
indexes, analyzes and interprets billions of molecular, clinical,
operational and financial data points derived from novel and traditional
sources, continuously improves decision-making and further optimizes our
clinical pathways and decision algorithms over time. For more
information please visit www.nanthealth.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170328006330/en/
for NantHealth, Inc.
Investor Contact:
Robert Jaffe
424.288.4098
rjaffe@rjaffeco.com
Source: NantHealth, Inc.